| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
KOSDAQ |
|
|
| Address |
404-10,NOJANG-RI, JEONDONG-MYEON, YEONGI-GUN, CHUNGNAM |
| Home Page |
www.kup.co.kr
|
| Established |
1987.12. 3 |
Tel |
041-862-5030 |
| Listed |
1999.11.11 |
IR |
|
| Common shares O/S |
15,025,924 |
President |
Kang,Duk Young |
| Preferred shares O/S |
|
No.of Employees |
395(2007. 6) |
| The sales has gone up due to the sales of the new products, launched recently based on the medicine technology as of Mar., 2007. The profitability has gone up due to the increased sales of the synthetic products of high margin. The sales and the profitability improvement will continue due to the brisk sales of the new products since Apr., 2007. |
| The sound growth will be possible due to the new products launched, whose cost is low resulting from its own pruduction by its technology. The operating profitability will go up with the leverage effect amid the concerns on the expenses increase for the development of the new customers amid the recruitment. The current net profit will go up with the gain on the equity method evaluation amid the high growth of the local company in Vietnam. |
|
  |
(date: 2007.06, unit : %) |
| Name |
Kang Deogyeong |
Kang Yena |
Kang Wonil |
| Portion |
45.3 |
0.0 |
0.0 |
|
  |
(unit : %) |
| Sales |
Antibiotics |
32.6 |
Cost |
Raw Materials |
|
| Gastrointestinal System Drugs |
14.3 |
Labors |
|
| Others |
20.2 |
Overhead |
|
|
  |
(Unit : 100Mn.Won,Won) |
| Year |
99.11 |
~00.12 |
01. 2 |
~01.12 |
~05.12 |
| Type |
LI |
CB |
SS |
CB |
CB |
| Amount |
62.50 |
1.58 |
500.00 |
7.92 |
3.14 |
|
|
|
|